Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Sterile alpha motif and HD domain-containing protein 1 (SAMHD1) is an enzyme encoded by the SAMHD1 gene in humans. It catalyzes the hydrolysis of deoxynucleoside triphosphates (dNTPs) into deoxynucleosides and inorganic triphosphate, thereby tightly regulating the intracellular dNTP pool. This activity is crucial for limiting the availability of nucleotides required for viral reverse transcription, making SAMHD1 a cell-intrinsic restriction factor against HIV-1 and other retroviruses. SAMHD1 is also involved in maintaining genome stability and facilitating DNA double-strand break repair, independent of its dNTPase activity. Mutations in SAMHD1 are linked to the autoimmune disease Aicardi-Goutières syndrome and chronic lymphocytic leukemia. While no clinically approved therapies directly target SAMHD1 as of September 2025, its function is manipulated by certain lentiviral proteins, such as Vpx, and it is being explored as a potential target for modulating immune responses and viral replication.
Inhibitors would modulate (usually inhibit) SAMHD1 dNTPase activity, increasing dNTP levels and potentiating viral replication or DNA synthesis.\nActivators or mimetics may enhance dNTPase function, reducing nucleotide pools and restricting viral replication.\nIndirect modulation via the Vpx protein (in HIV-2 and related viruses) targets SAMHD1 for proteasomal degradation, lifting its restriction on HIV-1 replication.
2 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Sterile alpha motif and HD domain-containing protein 1 (SAMHD1).